Transplant drug could boost the power of brain tumor treatments
- Details
- Category: Research
Every day, organ transplant patients around the world take a drug called rapamycin to keep their immune systems from rejecting their new kidneys and hearts. New research suggests that the same drug could help brain tumor patients by boosting the effect of new immune-based therapies.
New research outlines promising therapies for small cell lung cancer
- Details
- Category: Research
Two recently published studies by a research team at University Hospitals (UH) Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and "is a disease in urgent need of new drug therapies," write the study's authors.
Discrepancies in access to new cancer drugs revealed
- Details
- Category: Research
Access to potentially life-extending cancer drugs varies significantly in different regions of the world, two new studies show at the ESMO 2014 Congress in Madrid, Spain. Researchers say the results demonstrate the need for better collaboration between doctors and health authorities on an international scale, to ensure patients have access to the best treatments.
Stanford researchers create 'evolved' protein that may stop cancer from spreading
- Details
- Category: Research
A team of Stanford researchers has developed a protein therapy that disrupts the process that causes cancer cells to break away from original tumor sites, travel through the blood stream and start aggressive new growths elsewhere in the body. This process, known as metastasis, can cause cancer to spread with deadly effect.
Single dose of antidepressant changes the brain
- Details
- Category: Research
A single dose of antidepressant is enough to produce dramatic changes in the functional architecture of the human brain. Brain scans taken of people before and after an acute dose of a commonly prescribed SSRI (serotonin reuptake inhibitor) reveal changes in connectivity within three hours, say researchers who report their observations in the Cell Press journal Current Biology on September 18.
Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse?
- Details
- Category: Research
High school biology taught us that we inherit certain traits from our parents that are pre-determined. But what if you could change how these genes play out by taking certain drugs or better yet, just changing your diet? That's exactly what a team of researchers at the Boston University School of Medicine (BUSM) have proposed through their research of epigenetics research.
What's more effective: Generic or brand-name statins?
- Details
- Category: Research
Statins are the most frequently prescribed drugs in the United States and are effective in reducing cardiovascular events. However, evidence suggests that patients do not always take these medications as prescribed and may not receive their full benefit. Researchers from Brigham and Women's Hospital (BWH), Harvard Medical School and CVS Health investigated whether the use of generic versus brand-name statins can play a role in medication adherence and whether or not this leads to improved health outcomes.
More Pharma News ...
- Researcher develops and proves effectiveness of new drug for spinal muscular atrophy
- Diabetes researchers find faster way to create insulin-producing cells
- Blocking one receptor on cells could halt rheumatoid arthritis
- Discovery paves the way for a new generation of chemotherapies
- Researchers improve severe asthma care through new, antibody-based treatment
- Oxidized LDL might actually be 'good guy'
- Scientists discover how to 'switch off' autoimmune diseases